Literature DB >> 28164027

Developmental delay and behavioral disorders in 59 HIV-exposed uninfected infants.

Véronique Reliquet1, Cécile Brunet-Cartier1, Elise Launay2, François Raffi1.   

Abstract

BACKGROUND: Antiretroviral therapy (ART) in HIV pregnant women has led to a dramatic decrease in the rate of HIV mother-to-child transmission but this benefit is counterbalanced with adverse effects related to in utero and neonatal exposure to ART. In 2013, some parents described neurodevelopmental disorders in their children.
METHODS: A standardized letter was sent to the 133 women who delivered in Nantes hospital from 01/01/2003 to 31/12/2012 (167 births).
RESULTS: Response rate was 33%. Over a 10-year period, 7 children had behavioral disorders and/or cognitive/developmental delay, 1 child had developmental delay + growth retardation and 2 experienced cancer.
CONCLUSIONS: We found a significant association between neurodevelopmental disorders, preterm birth and exposure to 3 nucleoside reverse transcriptase inhibitors (NRTIs). Further studies are needed and long-term follow-up into adulthood should continue.

Entities:  

Keywords:  Behavioral disorders; HIV-exposed uninfected infants (HEU); developmental delay

Year:  2017        PMID: 28164027      PMCID: PMC5253263          DOI: 10.21037/tp.2016.04.03

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


  13 in total

1.  A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.

Authors:  Ariane Alimenti; John C Forbes; Tim F Oberlander; Deborah M Money; Ruth E Grunau; Michael P Papsdorf; Evelyn Maan; Lesley J Cole; David R Burdge
Journal:  Pediatrics       Date:  2006-08-28       Impact factor: 7.124

2.  Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.

Authors:  Sarah K Himes; Yanling Huo; George K Siberry; Paige L Williams; Mabel L Rice; Patricia A Sirois; Toni Frederick; Rohan Hazra; Marilyn A Huestis
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

Review 3.  Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.

Authors:  Shirin Heidari; Lynne Mofenson; Mark F Cotton; Richard Marlink; Pedro Cahn; Elly Katabira
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-01       Impact factor: 3.731

4.  Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.

Authors:  Antoni Noguera; Claudia Fortuny; Carmen Muñoz-Almagro; Emilia Sanchez; M Antonia Vilaseca; Rafael Artuch; Jordi Pou; Rafael Jimenez
Journal:  Pediatrics       Date:  2004-10-18       Impact factor: 7.124

5.  Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Authors:  Paige L Williams; Miguel Marino; Kathleen Malee; Susan Brogly; Michael D Hughes; Lynne M Mofenson
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

6.  Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.

Authors:  Patricia A Sirois; Yanling Huo; Paige L Williams; Kathleen Malee; Patricia A Garvie; Betsy Kammerer; Kenneth Rich; Russell B Van Dyke; Molly L Nozyce
Journal:  Pediatr Infect Dis J       Date:  2013-06       Impact factor: 2.129

7.  Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.

Authors:  Béatrice Barret; Marc Tardieu; Pierre Rustin; Catherine Lacroix; Brigitte Chabrol; Isabelle Desguerre; Catherine Dollfus; Marie-Jeanne Mayaux; Stéphane Blanche
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

8.  Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11).

Authors:  Jeanne Sibiude; Laurent Mandelbrot; Stéphane Blanche; Jérôme Le Chenadec; Naima Boullag-Bonnet; Albert Faye; Catherine Dollfus; Roland Tubiana; Damien Bonnet; Nathalie Lelong; Babak Khoshnood; Josiane Warszawski
Journal:  PLoS Med       Date:  2014-04-29       Impact factor: 11.069

9.  Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants.

Authors:  Lynne M Mofenson; D Heather Watts
Journal:  PLoS Med       Date:  2014-04-29       Impact factor: 11.069

10.  Preterm birth time trends in Europe: a study of 19 countries.

Authors:  J Zeitlin; K Szamotulska; N Drewniak; A D Mohangoo; J Chalmers; L Sakkeus; L Irgens; M Gatt; M Gissler; B Blondel
Journal:  BJOG       Date:  2013-05-24       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.